Fig. 4From: Redox/NIR dual-responsive MoS2 for synergetic chemo-photothermal therapy of cancerBiocompatibility of MoS2–SS–HA. a Percentages of RBC hemolysis induced by MoS2–SS–HA at various concentrations. Inset: images for direct observation of hemolysis. b Viabilities of A549 and HELF cells after incubation with cell medium containing various concentrations of MoS2–SS–HA for 48 hBack to article page